Latest Eagle Health Investments LP Stock Portfolio
Eagle Health Investments LP Performance:
2024 Q3: 8.13%YTD: 24.04%2023: -3.17%
Performance for 2024 Q3 is 8.13%, and YTD is 24.04%, and 2023 is -3.17%.
About Eagle Health Investments LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Eagle Health Investments LP reported an equity portfolio of $528 Millions as of 30 Sep, 2024.
The top stock holdings of Eagle Health Investments LP are NTRA, ILMN, . The fund has invested 10.4% of it's portfolio in NATERA INC and 9.6% of portfolio in ILLUMINA INC.
The fund managers got completely rid off IQVIA HLDGS INC (IQV) and GUARDANT HEALTH INC (GH) stocks. They significantly reduced their stock positions in TRANSMEDICS GROUP INC (TMDX), INTUITIVE SURGICAL INC (ISRG) and UNITED THERAPEUTICS CORP DEL (UTHR). Eagle Health Investments LP opened new stock positions in NEUROCRINE BIOSCIENCES INC (NBIX). The fund showed a lot of confidence in some stocks as they added substantially to BIOMARIN PHARMACEUTICAL INC (BMRN), DEXCOM INC (DXCM) and ILLUMINA INC (ILMN).
The top stock holdings of Eagle Health Investments LP are NTRA, ILMN, . The fund has invested 10.4% of it's portfolio in NATERA INC and 9.6% of portfolio in ILLUMINA INC.
The fund managers got completely rid off IQVIA HLDGS INC (IQV) and GUARDANT HEALTH INC (GH) stocks. They significantly reduced their stock positions in TRANSMEDICS GROUP INC (TMDX), INTUITIVE SURGICAL INC (ISRG) and UNITED THERAPEUTICS CORP DEL (UTHR). Eagle Health Investments LP opened new stock positions in NEUROCRINE BIOSCIENCES INC (NBIX). The fund showed a lot of confidence in some stocks as they added substantially to BIOMARIN PHARMACEUTICAL INC (BMRN), DEXCOM INC (DXCM) and ILLUMINA INC (ILMN).
Eagle Health Investments LP Annual Return Estimates Vs S&P 500
Our best estimate is that Eagle Health Investments LP made a return of 8.13% in the last quarter. In trailing 12 months, it's portfolio return was 33.49%.
New Buys
| Ticker | $ Bought |
|---|---|
| neurocrine biosciences inc | 14,817,300 |
New stocks bought by Eagle Health Investments LP
Additions
| Ticker | % Inc. |
|---|---|
| biomarin pharmaceutical inc | 80.85 |
| dexcom inc | 63.75 |
| illumina inc | 21.52 |
| ultragenyx pharmaceutical in | 7.09 |
Additions to existing portfolio by Eagle Health Investments LP
Reductions
| Ticker | % Reduced |
|---|---|
| transmedics group inc | -86.41 |
| intuitive surgical inc | -73.88 |
| united therapeutics corp del | -67.7 |
| unitedhealth group inc | -41.66 |
| argenx se | -15.64 |
| icon plc | -12.57 |
| procept biorobotics corp | -9.34 |
| natera inc | -9.03 |
Eagle Health Investments LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| guardant health inc | -18,105,100 |
| iqvia hldgs inc | -25,773,500 |
Eagle Health Investments LP got rid off the above stocks
Sector Distribution
Eagle Health Investments LP has about 84.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 84.8 |
| Others | 15.2 |
Market Cap. Distribution
Eagle Health Investments LP has about 63.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 57.5 |
| MID-CAP | 20 |
| UNALLOCATED | 15.5 |
| MEGA-CAP | 5.7 |
Stocks belong to which Index?
About 38.6% of the stocks held by Eagle Health Investments LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 61.4 |
| S&P 500 | 22 |
| RUSSELL 2000 | 16.6 |
Eagle Health Investments LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Eagle Health Investments LP
Eagle Health Investments LP has 24 stocks in it's portfolio. About 71.7% of the portfolio is in top 10 stocks. DXCM proved to be the most loss making stock for the portfolio. EXAS was the most profitable stock for Eagle Health Investments LP last quarter.
Last Reported on: 12 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AGIO | agios pharmaceuticals inc | 2.78 | 330,830 | 14,698,800 | unchanged | 0.00 | ||
| ALNY | alnylam pharmaceuticals inc | 3.97 | 76,256 | 20,972,700 | unchanged | 0.00 | ||
| BMRN | biomarin pharmaceutical inc | 5.58 | 419,212 | 29,466,400 | added | 80.85 | ||
| DXCM | dexcom inc | 5.73 | 451,492 | 30,268,000 | added | 63.75 | ||
| EXAS | exact sciences corp | 7.02 | 544,200 | 37,070,900 | unchanged | 0.00 | ||
| FDMT | 4d molecular therapeutics in | 0.95 | 462,911 | 5,004,070 | unchanged | 0.00 | ||
| GH | guardant health inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| HOWL | werewolf therapeutics inc | 0.28 | 700,000 | 1,484,000 | unchanged | 0.00 | ||
| ILMN | illumina inc | 9.57 | 387,354 | 50,514,800 | added | 21.52 | ||
| IMCR | immunocore hldgs plc | 0.27 | 46,300 | 1,441,320 | unchanged | 0.00 | ||
| INSM | insmed inc | 7.10 | 513,700 | 37,500,100 | unchanged | 0.00 | ||
| INSP | inspire med sys inc | 5.46 | 136,603 | 28,830,100 | unchanged | 0.00 | ||
| IQV | iqvia hldgs inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ISRG | intuitive surgical inc | 0.69 | 7,390 | 3,630,480 | reduced | -73.88 | ||
| LNTH | lantheus hldgs inc | 0.90 | 43,200 | 4,741,200 | unchanged | 0.00 | ||
| NBIX | neurocrine biosciences inc | 2.81 | 128,600 | 14,817,300 | new | |||
| NTRA | natera inc | 10.37 | 431,314 | 54,755,300 | reduced | -9.03 | ||
| PRCT | procept biorobotics corp | 3.54 | 233,089 | 18,675,100 | reduced | -9.34 | ||
| RARE | ultragenyx pharmaceutical in | 5.91 | 561,700 | 31,202,400 | added | 7.09 | ||
| TMDX | transmedics group inc | 0.54 | 18,061 | 2,835,580 | reduced | -86.41 | ||